All Columns articles – Page 4
-
OpinionCheap virgin plastic limits recycling potential
Global plastic treaty negotiations risk being derailed by minority opposed to production caps
-
Opinion‘Creative destruction’ in the chemistry lab
Some obsolete lab equipment is quickly replaced, while other items are stubbornly persistent. What modern tech will survive to the 2060s?
-
OpinionIntergovernmental panel on chemicals, waste and pollution needs diverse input
Balancing industrial expertise against unwanted commercial influence is not easy but shouldn’t be discounted
-
OpinionLosing sleep over pesticide exposure
Managing exposure risks poses questions about the extent of producers’ and regulators’ responsibilities for safety
-
OpinionThe atomic weights of most chemical elements aren’t constant
But those values are constantly refined
-
OpinionChina’s drug development charge
Reforms and state support have fuelled domestic and foreign investment in pharmaceutical
-
OpinionChemistry ‘deserts’ threaten to push poorer undergraduates out
Course and departmental closures in the UK are creating ‘cold spots’, leaving students high and dry
-
-
BusinessWill HIV prevention get where it’s needed?
Gilead and its partners’ efforts to distribute generic lenacapavir could be derailed by cuts in international aid budgets
-
OpinionGetting good at human tasks
’What do you mean you had to lock the NMR with an oscilloscope and shim the magnet by hand?’
-
OpinionChemistry's capital C
From refinery scale to a nanosecond existence, carbon is everywhere – in life as well as chemistry
-
OpinionCritical metals supply strained
Conflict - both military and political - is having profound effects on supplies of a wide range of materials
-
OpinionThe future of oil refining in the UK
Can plants adapt to be compatible with a lower-carbon environment?
-
OpinionNon-hallucinogenic psychedelics
Chemical insights and advances are contributing to a new therapeutic avenue for mental health conditions
-
OpinionSafety is everyone’s responsibility
Maintaining culture and investment is key, especially in the absence of incidents
-
OpinionIgnoring women’s health shouldn’t be an option
Developing therapies for conditions that predominantly affect women is a neglected, but enormous, opportunity
-
OpinionWomen are not just another confounding factor in drug development
Ignoring physiological differences between the sexes is indefensible
-
OpinionRebuilding pharma supply chains
Multinationals are promising huge US investments, but it’s not all because of Trump’s policies
-
OpinionIran port explosion highlights issues of shipping hazardous chemicals
Intersecting regulations and jurisdictions mean rules can be accidentally or deliberately overlooked
-
OpinionIn search of truth and rules
To codify and predict ever more complex phenomena is one of science’s great drivers